English

SARS-CoV-2/Influenza A+B/RSV Antigen Combo Rapid Test

The SARS-CoV-2/Influenza A+B/RSV Antigen Combo Rapid Test (Nasopharyngeal Swab) is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 Nucleocapsid protein, Influenza A, Influenza B and Respiratory Syncytial Virus(RSV) antigens in nasopharyngeal swab specimens from individuals with suspected SARS-CoV-2/Influenza/RSV infection in conjunction with clinical presentation and the results of other laboratory tests.

Features

Fast (15minutes)

Simple Operation (Less Training Required)

Objective (Results Read by Analyzer)

High Accuracy


Specification

Product features Parameters
FormatCassette
SpecimenNasopharyngeal Swab
CertificateCE
Reading Time15 minutes
Storage Temperature2-30°C
SensitivitySARS-CoV-2: 97.1%; Influenza A+B: Type A(95.0%), Type B(92.9%); RSV: 94.3%
SpecificitySARS-CoV-2: 99.1%; Influenza A+B: Type A(99.1%), Type B(99.1%); RSV: 96.2%
AccuracySARS-CoV-2: 98.2%; Influenza A+B: Type A(98.4%), Type B(98.1%); RSV: 95.9%

Ordering Information

Cat. No. Product Specimen PackCut-off
ISIR-R535 SARS-CoV-2/Influenza A+B/RSV Antigen Combo Rapid Test Nasopharyngeal Swab